Watkins Tim

CMO & Head of DevelopmentContineum Therapeutics, Inc. (CTNM) · full profile →Form 4 · filed Jan 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$51K
Net Open-Market Flow
-$51K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2026Sell(S)3K$14.09$39K811
Jan 28, 2026Option exercise(M)4K$4.50$16K4K
Jan 28, 2026Sell(S)811$14.48$12K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2026Grant(A)160K$0160K
Jan 28, 2026Option exercise(M)4K$0253K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-002575) within minutes of acceptance. Every field above traces to the original document. Verify it directly: